| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |